Chen C, Chang C, Lee I, Huang C, Lin F, Lin S
Cell Cycle. 2023; 22(21-22):2409-2423.
PMID: 38129288
PMC: 10802207.
DOI: 10.1080/15384101.2023.2296184.
Di Bartolo B, Cartland S, Genner S, Manuneedhi Cholan P, Vellozzi M, Rye K
J Diabetes Res. 2021; 2021:6668506.
PMID: 34095317
PMC: 8163542.
DOI: 10.1155/2021/6668506.
Bonacina F, Pirillo A, Catapano A, Norata G
Cells. 2021; 10(5).
PMID: 33947039
PMC: 8146776.
DOI: 10.3390/cells10051061.
Primer K, Psaltis P, Tan J, Bursill C
Int J Mol Sci. 2020; 21(10).
PMID: 32455604
PMC: 7279383.
DOI: 10.3390/ijms21103633.
Hui N, Phan K, Kerferd J, Lee M, Mobbs R
J Spine Surg. 2020; 5(4):393-403.
PMID: 32042989
PMC: 6989925.
DOI: 10.21037/jss.2019.09.27.
Role of High-Density Lipoproteins in Cholesterol Homeostasis and Glycemic Control.
Manandhar B, Cochran B, Rye K
J Am Heart Assoc. 2020; 9(1):e013531.
PMID: 31888429
PMC: 6988162.
DOI: 10.1161/JAHA.119.013531.
High-fat diet protects the blood-brain barrier in an Alzheimer's disease mouse model.
Elhaik Goldman S, Goez D, Last D, Naor S, Liraz Zaltsman S, Sharvit-Ginon I
Aging Cell. 2018; 17(5):e12818.
PMID: 30079520
PMC: 6156545.
DOI: 10.1111/acel.12818.
The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications.
Wong N, Nicholls S, Tan J, Bursill C
Int J Mol Sci. 2018; 19(6).
PMID: 29874886
PMC: 6032203.
DOI: 10.3390/ijms19061680.
Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus.
Lucchesi D, Popa S, Sancho V, Giusti L, Garofolo M, Daniele G
Cardiovasc Diabetol. 2018; 17(1):78.
PMID: 29866130
PMC: 5987640.
DOI: 10.1186/s12933-018-0720-1.
Type 2 diabetes is associated with loss of HDL endothelium protective functions.
Vaisar T, Couzens E, Hwang A, Russell M, Barlow C, DeFina L
PLoS One. 2018; 13(3):e0192616.
PMID: 29543843
PMC: 5854245.
DOI: 10.1371/journal.pone.0192616.
Pharmacological Intervention to Modulate HDL: What Do We Target?.
Woudberg N, Pedretti S, Lecour S, Schulz R, Vuilleumier N, James R
Front Pharmacol. 2018; 8:989.
PMID: 29403378
PMC: 5786575.
DOI: 10.3389/fphar.2017.00989.
Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.
Srivastava R
Mol Cell Biochem. 2017; 440(1-2):167-187.
PMID: 28828539
DOI: 10.1007/s11010-017-3165-z.
New Era of Lipid-Lowering Drugs.
Barter P, Rye K
Pharmacol Rev. 2016; 68(2):458-75.
PMID: 26983688
PMC: 4813424.
DOI: 10.1124/pr.115.012203.
Bone mineral density and cardiovascular risk factors in postmenopausal women with coronary artery disease.
Alissa E, Alnahdi W, Alama N, Ferns G
Bonekey Rep. 2015; 4:758.
PMID: 26587227
PMC: 4644069.
DOI: 10.1038/bonekey.2015.127.
High Density Lipoprotein Cholesterol Increasing Therapy: The Unmet Cardiovascular Need.
Cimmino G, Ciccarelli G, Morello A, Ciccarelli M, Golino P
Transl Med UniSa. 2015; 12:29-40.
PMID: 26535185
PMC: 4592041.
Non-clinical development of CER-001.
Barbaras R
Front Pharmacol. 2015; 6:220.
PMID: 26500552
PMC: 4594020.
DOI: 10.3389/fphar.2015.00220.
Investigating the Effect of a Single Infusion of Reconstituted High-Density Lipoprotein in Patients with Symptomatic Carotid Plaques.
Nasr H, Torsney E, Poston R, Hayes L, Gaze D, Basser R
Ann Vasc Surg. 2015; 29(7):1380-91.
PMID: 26140943
PMC: 6419536.
DOI: 10.1016/j.avsg.2015.04.084.
Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury.
Brulhart-Meynet M, Braunersreuther V, Brinck J, Montecucco F, Prost J, Thomas A
PLoS One. 2015; 10(3):e0119664.
PMID: 25781943
PMC: 4362758.
DOI: 10.1371/journal.pone.0119664.
Reconstituted high-density lipoprotein therapies: a cause for optimism.
Javaheri A, Kolansky D, Cuchel M
Arterioscler Thromb Vasc Biol. 2014; 34(9):1800-2.
PMID: 25142879
PMC: 4560112.
DOI: 10.1161/ATVBAHA.114.304156.
HDL-targeted therapies: progress, failures and future.
Kingwell B, Chapman M, Kontush A, Miller N
Nat Rev Drug Discov. 2014; 13(6):445-64.
PMID: 24854407
DOI: 10.1038/nrd4279.
